News and Stories

Get to know HBHI's director and Bloomberg Distinguished Professor of Health Economics and Policy Daniel Polsky, PhD.

The U.S. population is living longer and tens of millions will need long-term care, whether at home or in a nursing home (which costs more than $90,000 a year). Yet only about one in ten families have long-term care insurance, which is expensive. Much of the caregiving as well as the financial burden falls on family members; and families deplete assets, ending up on Medicaid. Watch our conversation on possible solutions – and how to re-ignite a conversation about them.

Johns Hopkins University just announced its 35 Discovery Award winners for 2023. Hopkins Business of Health Initiative is excited to announce that two of these projects will be awarded additional seed grant funding by HBHI.

This webinar focused on the ways that CMOs are working to influence the health of organizations and their stakeholders (including not only employees, but customers and broader social stakeholders). We looked at new, innovative solutions CMOs are using to address health in business to understand the cutting-edge ways that health is being brought into business.

Nursing faces critical issues, resulting in the current nursing crisis. How do we understand the nuances impacting the profession, build mutual understanding, and find solutions? The panelists represented varied perspectives across the nursing workforce. They addressed the impacts of the shortage, strategies for addressing it, and the role of policy in solutions.

Get to know Kathryn McDonald, PhD, MM, Bloomberg Distinguished Professor of Health Systems, Quality and Safety.

It’s clear that changes in telehealth policy, mobile technology development, and consumer demand have fundamentally reshaped mental health treatment and substance use care in the US and around the world. What does this mean for people’s outcomes, specifically behavioral health care access, quality, and cost?

Get to know Joanne Kenen, the first Commonwealth Fund Journalist in Residence at the Bloomberg School of Public Health.

For many years, there has been a collective excitement about using artificial intelligence in healthcare delivery. Still, AI technology is often talked about as if it is science fiction and the future of healthcare. Despite the FDA's approval of more than 500 medical AI systems by July 2022, many experts question if AI is a reality in the medical arena, or if it remains far in the future—and how to overcome the obstacles to adopting the new technologies?

Get to know the Director of the Institute for Health and Productivity Studies at the Bloomberg School of Public Health and HBHI Affiliate Ron Goetzel